In a clinical trial spanning more than 10,000 patients, an artificial intelligence system developed by Alibaba's DAMO Academy found 15 cases of liver cancer that trained physicians had not detected — each one a life whose treatment path quietly shifted because a machine noticed what human attention had missed. The findings, published in Nature Medicine, arrive at a moment when AI is moving from the margins of medicine toward its center, not as a replacement for clinical judgment but as a kind of distributed second sight. Across imaging, personalized vaccines, and real-time surgery, the questio
Alibaba's AI Model Detects 15 Missed Liver Cancers in Nature Medicine Study
15 patients with missed liver metastasis diagnoses gained access to timely treatment options after AI detection enabled treatment plan adjustments.